Researchers from the University of Texas Southwestern have developed an aerosolized, mutated form of ACE2 that effectively neutralizes various SARS-CoV-2 variants in both cell cultures and mice. The study suggests that this modified ACE2 has promising preventive and therapeutic potential against COVID-19, especially with its easy aerosolized administration.
ATS completes acquisition of Avidity Science
ATS Corporation (“ATS”), today announced the successful completion of its acquisition of Avidity Science, LLC (“Avidity”), a growing designer and manufacturer of automated water purification solutions for biomedical
August 27, 2024